HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

AbstractOBJECTIVE:
Hypospadias is a frequent congenital anomaly but in most cases an underlying cause is not found. Steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) is a key regulator of human sex development and an increasing number of SF-1 (NR5A1) mutations are reported in 46,XY disorders of sex development (DSD). We hypothesized that NR5A1 mutations could be identified in boys with hypospadias.
DESIGN AND METHODS:
Mutational analysis of NR5A1 in 60 individuals with varying degrees of hypospadias from the German DSD network.
RESULTS:
Heterozygous NR5A1 mutations were found in three out of 60 cases. These three individuals represented the most severe end of the spectrum studied as they presented with penoscrotal hypospadias, variable androgenization of the phallus and undescended testes (three out of 20 cases (15%) with this phenotype). Testosterone was low in all three patients and inhibin B/anti-Müllerian hormone (AMH) were low in two patients. Two patients had a clear male gender assignment. Gender re-assignment to male occurred in the third case. Two patients harbored heterozygous nonsense mutations (p.Q107X/WT, p.E11X/WT). One patient had a heterozygous splice site mutation in intron 2 (c.103-3A/WT) predicted to disrupt the main DNA-binding motif. Functional studies of the nonsense mutants showed impaired transcriptional activation of an SF-1-responsive promoter (Cyp11a). To date, adrenal insufficiency has not occurred in any of the patients.
CONCLUSIONS:
SF-1 (NR5A1) mutations should be considered in 46,XY individuals with severe (penoscrotal) hypospadias, especially if undescended testes, low testosterone, or low inhibin B/AMH levels are present. SF-1 mutations in milder forms of idiopathic hypospadias are unlikely to be common.
AuthorsBirgit Köhler, Lin Lin, Inas Mazen, Cigdem Cetindag, Heike Biebermann, Ilker Akkurt, Rainer Rossi, Olaf Hiort, Annette Grüters, John C Achermann
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 161 Issue 2 Pg. 237-42 (Aug 2009) ISSN: 1479-683X [Electronic] England
PMID19439508 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydroxyprogesterones
  • NR5A1 protein, human
  • Steroidogenic Factor 1
  • inhibin B
  • Testosterone
  • Inhibins
  • Dehydroepiandrosterone Sulfate
  • Anti-Mullerian Hormone
  • Follicle Stimulating Hormone
  • DNA
  • Hydrocortisone
Topics
  • Adrenal Insufficiency (blood, genetics)
  • Anti-Mullerian Hormone (blood)
  • Cohort Studies
  • DNA (chemistry, genetics)
  • Dehydroepiandrosterone Sulfate (blood)
  • Follicle Stimulating Hormone (blood)
  • Humans
  • Hydrocortisone (blood)
  • Hydroxyprogesterones (blood)
  • Hypospadias (blood, genetics)
  • Infant, Newborn
  • Inhibins (blood)
  • Male
  • Mutagenesis, Site-Directed
  • Mutation
  • Sequence Analysis, DNA
  • Steroidogenic Factor 1 (genetics)
  • Testosterone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: